{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:26:53Z","timestamp":1791260813495,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017599","name":"Science and Technology Program of Zhejiang Province","doi-asserted-by":"publisher","award":["2023KY371"],"award-info":[{"award-number":["2023KY371"]}],"id":[{"id":"10.13039\/501100017599","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bcp.2026.118216","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T06:41:58Z","timestamp":1783060918000},"page":"118216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Metabolic reprogramming underlying the synergistic effect of energy metabolism inhibitors and chemotherapeutics in TNBC"],"prefix":"10.1016","volume":"252","author":[{"given":"TingXiao","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangming","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5800-3624","authenticated-orcid":false,"given":"Jinping","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.bcp.2026.118216_b0005","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1158\/1055-9965.EPI-22-1133","article-title":"Recent mortality patterns and time trends for the major cancers in 47 countries worldwide","volume":"32","author":"Sedeta","year":"2023","journal-title":"Cancer Epidem Biomar"},{"issue":"1","key":"10.1016\/j.bcp.2026.118216_b0010","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jncc.2024.01.006","article-title":"Cancer incidence and mortality in China, 2022","volume":"4","author":"Han","year":"2024","journal-title":"J. National Cancer Center"},{"issue":"1","key":"10.1016\/j.bcp.2026.118216_b0015","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s12672-025-02198-8","article-title":"Advancements and limitations in traditional anti-cancer therapies: a comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy","volume":"16","author":"Zafar","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.bcp.2026.118216_b0020","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","article-title":"Cancer treatments: past, present, and future","volume":"286","author":"Sonkin","year":"2024","journal-title":"Cancer Genet-Ny"},{"issue":"6487","key":"10.1016\/j.bcp.2026.118216_b0025","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression","volume":"368","author":"Faubert","year":"2020","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.bcp.2026.118216_b0030","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","article-title":"Cancer metabolism: looking forward","volume":"21","author":"Mart\u00ednez-Reyes","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bcp.2026.118216_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111285","article-title":"5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition","volume":"137","author":"Sethy","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2026.118216_b0040","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2025.1702720","article-title":"Clinical application and drug resistance mechanism of gemcitabine","volume":"13","author":"Zhang","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118216_b0045","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s13402-025-01135-9","article-title":"The moonlighting functions of glycolytic enzymes in tumorigenesis","volume":"49","author":"Chen","year":"2026","journal-title":"Cell. Oncol."},{"issue":"5","key":"10.1016\/j.bcp.2026.118216_b0050","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3892\/ol.2021.12630","article-title":"Altered glycolysis results in drug-resistant in clinical tumor therapy","volume":"21","author":"Peng","year":"2021","journal-title":"Oncol. Lett."},{"issue":"18","key":"10.1016\/j.bcp.2026.118216_b0055","doi-asserted-by":"crossref","first-page":"8836","DOI":"10.1111\/jcmm.16842","article-title":"Targeting hexokinase 2 increases the sensitivity of oxaliplatin by Twist1 in colorectal cancer","volume":"25","author":"Zhang","year":"2021","journal-title":"J. Cell Mol. Med."},{"issue":"1","key":"10.1016\/j.bcp.2026.118216_b0060","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s12935-022-02681-0","article-title":"Combination treatment with hENT1 and miR-143 reverses gemcitabine resistance in triple-negative breast cancer","volume":"22","author":"Xi","year":"2022","journal-title":"Cancer Cell Int."},{"issue":"3","key":"10.1016\/j.bcp.2026.118216_b0065","doi-asserted-by":"crossref","first-page":"897","DOI":"10.7150\/ijbs.81609","article-title":"An overview: the diversified role of mitochondria in cancer metabolism","volume":"19","author":"Liu","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118216_b0070","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12929-023-00956-w","article-title":"Role of mitochondrial alterations in human cancer progression and cancer immunity","volume":"30","author":"Wang","year":"2023","journal-title":"J. Biomed. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118216_b0075","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13045-022-01313-4","article-title":"Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management","volume":"15","author":"Jin","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bcp.2026.118216_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114398","article-title":"Targeting mitochondria as a potential therapeutic strategy against chemoresistance in cancer","volume":"160","author":"Mukherjee","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.bcp.2026.118216_b0085","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41422-022-00614-0","article-title":"Comprehensive metabolomics expands precision medicine for triple-negative breast cancer","volume":"32","author":"Xiao","year":"2022","journal-title":"Cell Res."},{"key":"10.1016\/j.bcp.2026.118216_b0090","doi-asserted-by":"crossref","unstructured":"Y.H. Deng, Z.Y. Chen, P.X. Chen, Y.M. Xiong, C.L. Zhang, Q.Y. Wu, H.Q. Huang, S.Q. Yang, K. Zhang, T.C. He, W. Li, G.L. Ye, W. Luo, H.S. Wang, D. Zhou, ALKBH3-regulated m A of ALDOA potentiates glycolysis and doxorubicin resistance of triple negative breast cancer cells, Acta Pharm Sin B 15(6) (2025) 3092-3106.","DOI":"10.1016\/j.apsb.2025.04.018"},{"issue":"1","key":"10.1016\/j.bcp.2026.118216_b0095","article-title":"Deubiquitinase UCH-L1 confers paclitaxel resistance via stabilizing PKM2 to promote glycolysis in triple-negative breast cancer","volume":"17","author":"Chen","year":"2026","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.bcp.2026.118216_b0100","article-title":"Biguanides antithetically regulate tumor properties by the dose-dependent mitochondrial reprogramming-driven c-Src pathway","volume":"6","author":"Park","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.bcp.2026.118216_b0105","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70572","article-title":"Multiomics-driven drug-cell interaction network for chemotherapy sensitivity prediction in metabolically defined triple-negative breast cancer subtypes","volume":"29","author":"Zhang","year":"2025","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.bcp.2026.118216_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123651","article-title":"Targeted degradation of hexokinase 2 by a novel engineered bispecific chimeric liposome-based Nano-PROTACs for enhancing tumor chemotherapy","volume":"326","author":"Gong","year":"2026","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.bcp.2026.118216_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygeno.2024.110892","article-title":"FOXCUT regulates the malignant phenotype of triple-negative breast Cancer via the miR-337-3p\/ANP32E Axis","volume":"116","author":"Shi","year":"2024","journal-title":"Genomics"},{"issue":"2","key":"10.1016\/j.bcp.2026.118216_b0120","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jpha.2023.09.008","article-title":"Tanshinone IIA ameliorates energy metabolism dysfunction of pulmonary fibrosis using 13C metabolic flux analysis","volume":"14","author":"Shan","year":"2024","journal-title":"J. Pharm. Anal."},{"issue":"7","key":"10.1016\/j.bcp.2026.118216_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110391","article-title":"Blockage of citrate export prevents TCA cycle fragmentation via Irg1 inactivation","volume":"38","author":"Li","year":"2022","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.bcp.2026.118216_b0130","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nmeth.4512","article-title":"Identifying metabolites by integrating metabolome databases with mass spectrometry cheminformatics","volume":"15","author":"Lai","year":"2017","journal-title":"Nat. Methods"},{"issue":"4","key":"10.1016\/j.bcp.2026.118216_b0135","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41592-019-0358-2","article-title":"A cheminformatics approach to characterize metabolomes in stable-isotope-labeled organisms","volume":"16","author":"Tsugawa","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.bcp.2026.118216_b0140","article-title":"A novel synergistic drug combination of a mitogen-activated extracellular signal-regulated kinase inhibitor with [177Lu]Lu-rhPSMA-10.1 for prostate cancer treatment: results of a preclinical evaluation","volume":"146","author":"Foxton","year":"2025","journal-title":"Nucl. Med. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118216_b0145","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1158\/1535-7163.MCT-10-0688","article-title":"A combined preclinical therapy of cannabinoids and temozolomide against glioma","volume":"10","author":"Torres","year":"2011","journal-title":"Mol. Cancer Ther."},{"issue":"10","key":"10.1016\/j.bcp.2026.118216_b0150","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202256380","article-title":"Calculation of ATP production rates using the Seahorse XF Analyzer","volume":"24","author":"Desousa","year":"2023","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bcp.2026.118216_b0155","doi-asserted-by":"crossref","DOI":"10.1038\/s42255-026-01530-y","article-title":"Metformin inhibits mitochondrial complex I in intestinal epithelium to promote glycaemic control","author":"Sebo","year":"2026","journal-title":"Nature Metabolism"},{"key":"10.1016\/j.bcp.2026.118216_b0160","doi-asserted-by":"crossref","unstructured":"H.L. Yinghui Wang , Linchong Sun , Xin Chen , Haoran Wei , Caixia Suo , Junru Feng , Mengqiu Yuan , Shengqi Shen , Weidong Jia , Ying Wang , Huafeng Zhang , Zijun Li , Xiuying Zhong , Ping Gao Metformin sensitises hepatocarcinoma cells to methotrexate by targeting dihydrofolate reductase, Cell Death Dis 12 (2021) 902.","DOI":"10.1038\/s41419-021-04199-1"},{"issue":"1","key":"10.1016\/j.bcp.2026.118216_b0165","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cmet.2020.10.012","article-title":"Metabolic-pathway-based subtyping of triple-negative breast cancer reveals potential therapeutic targets","volume":"33","author":"Gong","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.bcp.2026.118216_b0170","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1060495","article-title":"Correlation between the Warburg effect and progression of triple-negative breast cancer","volume":"12","author":"Liu","year":"2023","journal-title":"Front. Oncol."},{"issue":"21","key":"10.1016\/j.bcp.2026.118216_b0175","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1158\/0008-5472.CAN-20-3242","article-title":"Oxidative phosphorylation is a metabolic vulnerability in chemotherapy-resistant triple-negative breast cancer","volume":"81","author":"Evans","year":"2021","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.bcp.2026.118216_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2025.167859","article-title":"Combined inhibition of hexokinase 2 and pyruvate dehydrogenase surmounts SHP2 inhibitor resistance in non-small cell lung cancer with hybrid metabolic state harboring KRAS Q61H mutation","volume":"1871","author":"Shan","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.bcp.2026.118216_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115464","article-title":"Glutamine metabolism in breast cancer and possible therapeutic targets","volume":"210","author":"Li","year":"2023","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118216_b0190","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1186\/s12967-023-04263-8","article-title":"Metformin and cancer hallmarks: shedding new lights on therapeutic repurposing","volume":"21","author":"Hua","year":"2023","journal-title":"J. Transl. Med."},{"issue":"3","key":"10.1016\/j.bcp.2026.118216_b0195","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3390\/ph17030396","article-title":"Metformin and breast cancer: current findings and future perspectives from preclinical and clinical studies","volume":"17","author":"Corleto","year":"2024","journal-title":"Pharmaceuticals-Base"},{"issue":"1","key":"10.1016\/j.bcp.2026.118216_b0200","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3390\/metabo16010060","article-title":"Mitochondrial redox vulnerabilities in triple-negative breast cancer: integrative perspectives and emerging therapeutic strategies","volume":"16","author":"Cruz-Gregorio","year":"2026","journal-title":"Metabolites"},{"issue":"13","key":"10.1016\/j.bcp.2026.118216_b0205","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1016\/j.molcel.2025.05.019","article-title":"Glucose-1-phosphate promotes compartmentalization of glycogen with the pentose phosphate pathway in CD8+memory T cells","volume":"85","author":"Zhou","year":"2025","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.bcp.2026.118216_b0210","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41419-024-06435-w","article-title":"Amino acid metabolism in tumor biology and therapy","volume":"15","author":"Chen","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2026.118216_b0215","first-page":"e39","article-title":"Polyamine metabolism in cancer: drivers of immune evasion, ferroptosis and therapy resistance","volume":"27","author":"Chenna","year":"2025","journal-title":"Expert Rev. Mol. Med."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226005551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226005551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:15:08Z","timestamp":1786652108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226005551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":43,"alternative-id":["S0006295226005551"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118216","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic reprogramming underlying the synergistic effect of energy metabolism inhibitors and chemotherapeutics in TNBC","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118216","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118216"}}